Press Releases

Oct 22, 2019

Veracyte Announces New Clinical Data Showing First-Ever Noninvasive Nasal Swab Test Can Enable Early Lung Cancer Detection and Diagnosis

Read More

Oct 21, 2019

Veracyte Announces Clinical Data Demonstrating Clinical Validity and Utility of Percepta Classifier in Lung Cancer Diagnosis When Bronchoscopy Results Are Inconclusive

Read More

Oct 21, 2019

Veracyte Announces New Data Demonstrating That Envisia Genomic Classifier Improves IPF Diagnosis

Read More

Oct 08, 2019

Veracyte to Release Third Quarter 2019 Financial Results and Business Progress on October 22, 2019

Read More

Oct 07, 2019

Veracyte to Announce New Clinical Data for First Noninvasive Nasal Swab Test to Target Early Lung Cancer Detection at CHEST Annual Meeting 2019

Read More

Sep 11, 2019

Veracyte Announces Publication of Clinical and Analytical Validation Data for Afirma Xpression Atlas

Read More

Sep 03, 2019

Veracyte Announces Publication of New Study Characterizing Gene Alterations in Thyroid Cancer

Read More

Aug 28, 2019

Veracyte to Present at Upcoming Investor Conferences

Read More

Jul 30, 2019

Veracyte Announces Second Quarter 2019 Financial Results

Read More

Jul 01, 2019

Veracyte Names Keith Kennedy Chief Operating Officer and Chief Financial Officer

Read More